Skip to Content

Texas Permanent School Fund purchased 35,690 shares of Enhabit, Inc. (NYSE:EHAB).

Texas Permanent School Fund purchased 35,690 shares of Enhabit, Inc. (NYSE:EHAB).

The most recent filing that the company has made with the Securities and Exchange Commission indicates that during the third quarter of this year, the Texas Permanent School Fund increased its holdings of Enhabit, Inc. (NYSE: E.H.A.B.). The institutional investor invested a little more than half a million dollars to purchase 35,690 shares of the company’s stock. After the most recent fiscal quarter, the Texas Permanent School Fund held 0.07% of Enhabit’s total shares in its portfolio.

Recent transactions involving other significant investors involved the buying and selling business stock. These transactions took place recently. During the third quarter of the current fiscal year, Sumitomo Mitsui Trust Holdings Inc. purchased 8,951,000 shares of Enhabit, bringing their total investment to $8,951,000. Wedge Capital Management L.L.P.L.L.P. has expanded its holdings in Enhabit by completing a new investment during the third quarter. Approximately $5,854,000 was exchanged as a result of this transaction. The State of Alaska Department of Revenue increased its investment in Enhabit by purchasing additional shares during the third quarter, bringing the total amount it has spent on the company to approximately $2,310,000. The addition of a new position in Enhabit by Strs Ohio during the second quarter resulted in an increase in revenue of approximately $3,262,000 for the company. Last but certainly not least, Foundry Partners L.L.C.L.L.C. shelled out approximately $1,571,000 during the third quarter to acquire a new holding in Enhabit shares. Institutional investors and hedge funds hold most of the company’s stock, accounting for 95.55 percent of the total.

The E.H.A.B. has been the subject of several reports compiled by specialists in various research fields. C.J.S.C.J.S. Securities started reporting on Enhabit on December 13, the day they opened their account. They graded the company as “market perform” and recommended its aim for a price of $18.00 for its shares. On Thursday, December 8, a research report was published by the UBS Group, in which they started covering Enhabit. They gave the company’s stock a ” sell ” rating and suggested a “sell” price of $12.00. Credit Suisse Group lowered its price objective for Enhabit from $19.00 to $15.00 and assigned the company a “neutral” rating in a research report published on Friday, November 4. The report’s subject matter was the company. Oppenheimer began providing coverage of Enhabit in the form of a research paper on Thursday, October 13. They rated the company’s performance in the market as “market perform” overall. On December 5, Stifel Nicolaus began providing coverage of Enhabit in the form of a research study. This is the last, but not the least, of the news. They recommended that the company “buy” the stock and establish a price objective of $17.00. Investment analysts recommend selling the stock at a rating of two out of four, holding the stock at a rating of four out of two, and buying the stock at a recommendation of two. According to Bloomberg.com, the average rating given to the stock right now is “Hold,” and the consensus regarding the price target for the stock is set at $16.43.

When trading started on Monday, one share of Enhabit stock was going for $13.52 per share. Enhabit, Inc. reached a 52-week high of $25.25 and a 52-week low of $11.65 during the period covered by this report. The current, quick, and debt-to-equity ratios are all equal, making the total ratio 1.5. The ratio of debt to equity is currently 0.63. According to the stock’s 50-day simple moving average price, the share price is currently at $13.28.

On November 1, the results of Enhabit’s most recent quarterly financial report were made public. Enhabit is traded on the NYSE under the symbol E.H.A.B. The company’s quarterly earnings came in at $0.19 per share, which was $0.09 less than expected, which was $0.28 per share on average. The amount of money the company made in sales during the period in question was $265.70 million, which was higher than the estimated $265.62 million that industry professionals provided. Enhabit had a return on equity of 7.62%, which was lower than its net margin of 7.76%. The projections of market research analysts put Enhabit, Inc.’s earnings per share for this year at $1.45, which is the amount anticipated for the company.

In addition, Director Jeffrey Bolton bought 2,000 shares of the company’s stock on November 9, bringing his total holdings to 4,000. The price of each share was determined to be, on average, $12.75, which resulted in the overall cost of the shares coming to $25,500.00. Following the successful completion of the acquisition, the director now directly owns 14,597 shares of the company’s stock. Considering their current market price, these shares have a value of $186,111.75. The Securities and Exchange Commission was given legal documentation about the transaction, which can be viewed entirely by following the link provided in the previous sentence. The documentation was provided to the S.E.CS.E.C. In addition, Director Jeffrey Bolton bought 2,000 shares of the company’s stock on November 9, bringing his total holdings to 4,000. The price of each share was determined to be, on average, $12.75, which resulted in the overall cost of the shares coming to $25,500.00.

Following the successful completion of the acquisition, the director now directly owns 14,597 shares of the company’s stock. Considering their current market price, these shares have a value of $186,111.75. The Securities and Exchange Commission was given legal documentation about the transaction, which can be viewed entirely by following the link provided in the previous sentence. The documentation was provided to the S.E.CS.E.C. In addition, Gregory S. Rush, a director of the company, purchased 8,300 shares of the company’s stock on November 7. The price paid for each share was $12.69 on average, bringing the total amount spent on the stock transactions to $105,327.00. The price that was paid per share on average was $12.69. Following the successful completion of the acquisition, the director now directly owns 16,597 shares of the company’s stock. The total value of these shares is $210,615.93. You should look in this location if you are looking for the disclosure that pertains to this transaction. Insiders have purchased 13,000 shares of company stock over the most recent three months, spending a total of $164,903 on the transaction.

Enhabit, Inc. provides hospice and home health care services across the United States. In addition to patient education, pain management wound care and dressing changes, cardiac rehabilitation, infusion therapy, and skilled observation and assessment, the home health services provided by the company include disease-specific treatment plans for chronic conditions such as diabetes, hypertension, arthritis, Alzheimer’s disease, low vision, spinal stenosis, Parkinson’s disease, osteoporosis, and chronic pain. Other services the company provides include wound care and dressing changes, cardiac rehabilitation, infusion therapy, and skilled observation and assessment.

Tags

Leave a comment

Your email address will not be published. Required fields are marked *